Floatz logo

Granisetron

Myofascial Pain

Karolinska InstitutetSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Myofascial Pain cohort.

Asset / SponsorPhaseRating
Imc-1
Innovative Med Concepts, LLC
Phase 2B
Capsaicin
Stamford Hospital
Phase 2CCC
Solvazinc
Cairo University
Early Phase 1C
BICARBONATE ION
Cairo University
N/AD
DEXTROSE
Ankara University
D

View all 12 →

Same molecule, other indications

Granisetron is also rated in:

cancer of unknown primary siteDormant
BB
Indicative ·
71 / 100
View asset →
temporomandibular joint disorderDormant
BB
Indicative ·
69 / 100
View asset →
NauseaDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →